epa01915079 (FILE) A fiile photo shows a worker handling vials of Humenza adjutant, a H1N1 flu vaccine produced by the Sanofi-Pasteur laboratories in Val-de-Reuil, France, 19 October 2009. The French Government is drawing criticism from different quarters who are claiming that the campaign against the influenza has, with 94 million vaccines ordered firm at a cost of 871 million euros, lacks transparency, has a disproportionate influence by the manufacturing laboratories or bad preparation for it in the hospitals. According to the French newspaper Le Parisien the group of appraise and information on the influenza (Geig), which advises the ministry for Health on a regular basis, 'is financed at 100 per cent by the vaccine producing laboratories against the influenza'. EPA/HORACIO VILLALOBOS | Location: VAL-DE-REUIL, FRANCE.
Not available for distribution, sale, or license by Corbis' international representatives.
Not available for use by the following France publications: L'Express, Le Point, Marianne, Paris Match, Nouvel Observateur, VSD, Expansion, Capital and Entreprendre.
Available for license and invoicing to customers located in the United States, Canada, the United Kingdom, Ireland, France, Italy, Macau, and Australia.
Uncompressed file sizes and pixel dimensions are approximate. Grayscale images are 1/3 the file size of RGB files. Files downloaded directly from the website are compressed JPEG format. You may request a TIFF file, if available, or a larger interpolated size for your output needs. Please contact Customer Service for associated production fees.